Dr. Ueberheide joined the faculty of NYU as the Director of the Proteomics Core. She will be establishing a fully integrated state of the art mass spectrometry laboratory focusing on proteomics. She has extensive experience in biological mass spectrometry especially method development, mapping of post translational modifications, de novo sequencing, Bottom Up and Top Down strategies, as well as comprehensive protein characterization in complex mixtures. Dr. Ueberheide contributed to a wide range of studies from analyzing chromatin, characterizing venoms, to sequencing of complex antibody mixtures. She received her PhD in chemistry at the University of Virginia where she focused on the study of histone post translational modifications using classical Bottom Up and also Top Down strategies. She joined Rockefeller University in 2006 for her postdoctoral training. There she developed de novo sequencing strategies for analysis of venom components and established techniques to study antibodies isolated from HIV infected long-term non-progressors. In her role as the director of proteomics she will enable the NYU faculty in their research efforts of understanding cellular function by characterizing proteins in a biological context. The current focus of her research is to develop advanced mass- spectrometry based techniques to characterize circulating antibodies and to understand the structure-function relationship of peptide toxins. She utilizes chemical strategies in combination with electron transfer dissociation to increase the biological relevant information obtained from mass spectrometric data.
Assistant Professor, Department of Biochemistry and Molecular Pharmacology
Director, Proteomics Resource Center
PhD from University of Virginia
Nature medicine. 2017 Apr 10; ?-?
Molecular & cellular proteomics. 2017 Mar 15; ?-?
Science. 2017 Mar 10; 355(6329):?-?
Acta neuropathologica. 2017 Mar 4; ?-?
Molecular & cellular proteomics. 2017 Feb 14; 16(4 suppl 1):S15-S28
Journal of the American Society for Mass Spectrometry. 2017 Jan 19; 28(5):803-810
A systems biology approach identifies FUT8 as a novel driver of melanoma metastasis [Meeting Abstract]
Glycobiology. 2016 Dec; 26(12):1447-1448
Molecular cell. 2016 Nov 03; 64(3):507-519